{"id":"W2129660553","doi":"10.1200/jco.2010.34.2766","title":"Long-Term Follow-Up of Women in Trials of Adjuvant Therapy for Breast Cancer: Is It Still Important?","year":2011,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"GlaxoSmithKline; AstraZeneca; American Society of Clinical Oncology; Pfizer","keywords":"Medicine; Tamoxifen; Breast cancer; Hazard ratio; Cancer; Cause of death; Randomized controlled trial; Adjuvant therapy; Internal medicine; Disease; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05234203,0.0006483905,0.003261684,0.001213649,0.001308041,0.004393951,0.00235457,0.007591899,0.002313007],"category_scores_gemma":[0.1844241,0.0005930173,0.001643122,0.002055242,0.001477846,0.004606917,0.0008853885,0.009447104,0.0008841299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001322255,"about_ca_system_score_gemma":0.002628438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001282023,"about_ca_topic_score_gemma":0.003661622,"domain_scores_codex":[0.9727304,0.0155764,0.005389813,0.001420496,0.004209851,0.0006729747],"domain_scores_gemma":[0.8048515,0.1465265,0.01785991,0.004706558,0.02169089,0.004364685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009443187,0.0001562759,0.01113021,0.009017169,0.002696073,0.0005924159,0.0008342939,0.0001602987,0.000500514,0.002655135,0.6152704,0.3475439],"study_design_scores_gemma":[0.009828119,0.004838701,0.06840215,0.03142057,0.01135637,0.001783394,0.00283802,0.00159496,0.001491768,0.02414002,0.8416487,0.0006572727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.005838288,0.2946557,0.0008215529,0.4634024,0.2332003,0.00007030449,0.0003153513,0.00005175427,0.001644435],"genre_scores_gemma":[0.04962185,0.2003502,0.001577779,0.1990834,0.5461797,0.0003020058,0.0003683182,0.0000974276,0.002419243],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.05234203,"threshold_uncertainty_score":0.2768144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09580322712969981,"score_gpt":0.435798097786311,"score_spread":0.3399948706566112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}